Related Experiment Videos

[The immunobiology of transplant rejection and its pharmacological modification]

H Köhler¹, B Zanker, T B Strom

¹I. Medizinische Klinik und Poliklinik, Universität Mainz.

Deutsche Medizinische Wochenschrift (1946)

|February 15, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survival.

Transplant international : official journal of the European Society for Organ Transplantation·2000

Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients.

Transplantation·1998

Aggressive treatment of the first acute rejection episode using first-line anti-lymphocytic preparation reduces further acute rejection episodes after human kidney transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·1998

Restricted T cell V beta repertoire in renal allografts during acute and chronic rejection.

Kidney international·1996

Mycophenolate mofetil in patients with acute renal failure: evidence of metabolite (MPAG) accumulation and removal by dialysis.

Transplant international : official journal of the European Society for Organ Transplantation·1996

The immunosuppressive effects of verapamil upon mitogen activated and allo-antigen inducible human cytotoxic T-lymphocytes.

International journal of immunopharmacology·1994

See all related articles